Follow

Time traveling to 1997, the Post covering the arrival of effective combination therapy for HIV. I like particularly like this bit:

'But David Ho didn't invent protease inhibitors. He is just one of a group of major international researchers, dubbed the "new guard" by the science press, who played a role in exploring their possibilities. And he is the first to acknowledge that the drug companies themselves -- usually the least likely source of groundbreaking science -- did most of the heavy lifting. "The feeling in the labs," recalls Merck CFO Judy Lewent, "was that this was Nobel laureate caliber work. And, in the drug industry, we don't get to think about that all too often."'

washingtonpost.com/archive/lif

Sign in to participate in the conversation
CleverLibre Social

CleverLibre Social is an inclusive social instance for open discussion, learning, and community.
All cultures welcome.
Hate speech and harassment strictly forbidden.